# Univercells Technologies

sells the scale-X platform, a fixed-bed perfusion bioreactor line scaling from a 0.5 m² scale-X nexo research system to a 600 m² scale-X nitro commercial-manufacturing configuration for vaccine and viral-vector production, engineered to overcome the scale-up limitations of traditional stirred-tank culture.


Source: https://en.bioecon.ru/companies/univercells-technologies/
Updated: 2026-08-14

- Country: Belgium

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Founded | 2020 | https://www.univercellstech.com/univercells-technologies-completes-nivelles-facility-expansion-tripling-manufacturing-and-rd-capacity/ |
| Headquarters | Nivelles, Belgium | https://www.donaldsonlifesciences.com/content/lifesciences/en/news/donaldson-acquires-univercells-technologies--broadens-life-scien.html, https://www.univercellstech.com/donaldson-acquires-univercells-technologies-broadens-life-sciences-reach/ |
| Production site | Nivelles, Belgium | https://www.univercellstech.com/univercells-technologies-completes-nivelles-facility-expansion-tripling-manufacturing-and-rd-capacity/ |
| Capacity | Bioreactor line scaling from 0.5 m² (nexo) to 200–600 m² (nitro) | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/, https://www.univercellstech.com/products/, https://www.univercellstech.com/products/scale-x-carbo/, https://www.univercellstech.com/products/scale-x-nexo-system/, https://www.univercellstech.com/products/scale-x-nitro-system/, https://www.univercellstech.com/univercells-technologies-by-donaldson-launches-thescale-x-nexo-mini-bioreactor-for-cost-efficient-scalable-cell-culture-process-development-across-modalities/ |
| Certification | Bioreactors are gamma irradiated and supplied with a full validation guide for GMP conditions | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/ |
| Regulatory approval | Technology used for clinical material production under GMP following FDA & EMA authority; NevoLine platform enables compliance to 21CFR part 11 | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/ |
| Headcount | 62.5 FTEs as of 2025; 68 employees as of July 2026 | https://www.companyweb.be/en/0741506996/univercells-technologies |
| Revenue | Approximately €10 million (calendar year 2022); €6,090,844 (2025 financial statements) | https://www.companyweb.be/en/0741506996/univercells-technologies, https://www.univercellstech.com/donaldson-acquires-univercells-technologies-broadens-life-sciences-reach/ |

Independent sources: companyweb.be, donaldsonlifesciences.com

## Technologies

- [High-cell-density culture systems](https://en.bioecon.ru/technology/high-cell-density-culture-systems/)
- [Seed-train automation systems](https://en.bioecon.ru/technology/seed-train-automation-systems/)